Peijia Medical Limited (HKG:9996)
Hong Kong
· Delayed Price · Currency is HKD 5.47
-0.11 (-1.97%)
Jun 6, 2025, 4:08 PM HKT
Peijia Medical Revenue
In the year 2024, Peijia Medical had annual revenue of 615.48M CNY with 39.53% growth. Peijia Medical had revenue of 314.28M in the half year ending December 31, 2024, with 138.03% growth.
Revenue
615.48M CNY
Revenue Growth
+39.53%
P/S Ratio
5.56
Revenue / Employee
587.85K CNY
Employees
1,047
Market Cap
3.64B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.53B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| Innovent Biologics | 10.03B |
| CSPC Pharmaceutical Group | 28.99B |
| WuXi Biologics | 19.87B |
| Sino Biopharmaceutical | 30.72B |
| Sichuan Kelun-Biotech Biopharmaceutical | 2.06B |